Murad Hussain is a trial and appellate attorney who represents individuals and entities in government investigations, False Claims Act (FCA) and other complex civil litigation, criminal prosecutions, administrative proceedings, and internal compliance reviews. He regularly defends healthcare providers and life sciences innovators facing allegations of healthcare fraud, kickbacks and bribery, and regulatory non-compliance. He also counsels multinational organizations and others on cross-border enforcement and compliance matters involving customs and tariff laws, export controls, and the Foreign Agents Registration Act (FARA). Across his practice, Murad has successfully defended clients in federal criminal jury trials, won dismissals of FCA qui tam lawsuits, and secured declinations and no-fault settlements for individuals and entities under investigation by the U.S. Department of Justice (DOJ), the U.S. Department of Health and Human Services Office of Inspector General (HHS-OIG), other federal agencies, and state Attorneys General.
Murad has been recognized by Best Lawyers for FCA qui tam defense and white collar criminal defense, by The Legal 500 as a “Next Generation Partner” for healthcare and life sciences matters, and by the Outpatient Endovascular and Interventional Society as a “Distinguished Friend.” He serves on the firm's Pro Bono Committee, as an Adjunct Professor of trial practice at the Georgetown University Law Center, and on the board of directors for Legal Services of Northern Virginia, and he was appointed by Virginia Supreme Court Chief Justice S. Bernard Goodwyn to serve on the faculty for the Virginia State Bar Harry L. Carrico Professionalism Course. Murad also regularly publishes and speaks on FCA, FARA, and data analytics-related enforcement matters.
Murad served as a law clerk to the Honorable Ellen Segal Huvelle of the U.S. District Court for the District of Columbia. He earned his law degree from Yale Law School, where he received the Potter Stewart Prize for best moot court team and the President's Public Service Fellowship. Before law school, he worked as a creative executive at a Hollywood studio-based production company.
Experience
- Cardiology, vascular surgery, interventional radiology, dermatology, ophthalmology, and oncology practices, in defending against civil False Claims Act and criminal healthcare fraud investigations by Main Justice, HHS-OIG, and U.S. Attorney's Offices across the country, and related qui tam litigation.
- Nonprofit research and treatment hospital, in advising on internal payment audits and charitable program compliance with the Anti-Kickback Statute and Beneficiary Inducement Statute.
- Multiple interventional cardiology practices, in winning the dismissal of two False Claims Act qui tam complaints in the Western District of Pennsylvania, concerning alleged violations of ambulatory surgical center licensing provisions, and securing affirmance by the U.S. Court of Appeals for the Third Circuit. U.S. ex rel. Stebbins v. Maraposa Surgical, Inc., No. 24-1626, 2024 WL 4947274 (3d Cir. Dec. 3, 2024), aff’g No. 1:22-CV-010, 2024 WL 1299705 (W.D. Pa. Mar. 27, 2024); U.S. ex rel. Stebbins v. Jefferson Cardiology Ass'n, P.C., No. 2:21-CV-1803, 2024 WL 3982318 (W.D. Pa. Aug. 29, 2024), appeal dismissed, No. 24-2743 (3d Cir. Dec. 10, 2024); U.S. ex rel. Stebbins v. Jefferson Cardiology Ass'n, P.C., No. 2:21-CV-1803, 2023 WL 11823355 (W.D. Pa. July 11, 2023).
- National hospital management company, in federal investigations, proceedings before the Judicial Panel on Multi-District Litigation, and multiple nationwide False Claims Act qui tam lawsuits alleging medically unnecessary emergency department services and physician kickbacks, as well as in related state court litigation. See In re Health Mgmt. Assocs., Inc. Qui Tam Litigation, MDL No. 2524; U.S. ex rel. Williams v. Health Mgmt. Assocs., et al., No. 3:09-CV-130 (M.D. Ga.); U.S. ex rel. France v. Health Mgmt. Assocs., et al., No. 8:13-CV-1264 (M.D. Fla.); U.S. ex rel. Dennis v. Health Mgmt. Assocs., et al., No. 3:09-CV-00484 (M.D. Tenn.).
- National home health care and hospice provider, in negotiating a no-fault overpayment settlement with DOJ and securing the dismissal of multiple False Claims Act qui tam suits concerning laboratory and diagnostic testing in the U.S. District Courts for the Eastern Districts of Michigan, Western District of Michigan, and the Southern District of Ohio.
- Mohs surgeon, in winning a complete acquittal after a 5-week federal criminal jury trial on charges of healthcare fraud and aggravated identity theft, following the government's related interlocutory appeal.
- Vascular surgery, interventional radiology, and wound care practices, in healthcare regulatory compliance counseling, HHS-OIG and Medicare contractor audits, and corporate strategy.
- Ophthalmic surgeon, in securing a mistrial after a 10-week criminal jury trial on bribery and related charges (where the jury deadlocked 10-2 for acquittal), and in successfully arguing for Rule 29 acquittal on all counts based on political contributions, leading to the dismissal of all remaining charges. U.S. v. Menendez, et al., 291 F. Supp. 3d 606, 623-35 (D.N.J. 2018).
- Various healthcare providers and vendors, in investigations and prosecutions by the U.S. Attorney's Office for the District of New Jersey concerning genetic testing laboratories and alleged kickbacks.
- Surgeon, in defending against a U.S. Attorney's Office criminal healthcare fraud and Controlled Substances Act investigation and securing the declination of all healthcare-related charges.
- Multi-state ophthalmology practice, in bringing a successful administrative challenge to reverse the deactivation of its Medicare enrollment.
- Surgeon, in a 7-week federal criminal jury trial in the Southern District of Florida on charges of Medicare fraud, and in the related appeal to the Eleventh Circuit.
- Executive at a private equity-backed healthcare services organization, in a successfully resolved DOJ healthcare fraud investigation of the company's compliance with Medicaid credentialing and supervisory requirements.
- Executive at a private equity-backed national healthcare services provider, in negotiating a nuisance-value no-fault settlement with DOJ and securing the dismissal of multiple False Claims Act qui tam suits.
- Surgical practice, in bringing a federal lawsuit and related appeal challenging an administrative Medicare overpayment determination.
- Private equity investor, in counseling on the potential acquisition of a healthcare entity under DOJ investigation.
- Functional medicine practice, in challenging a private payor overpayment determination.
- Specialty pharmacist, in administratively challenging exclusion from federal healthcare programs following a state misdemeanor conviction.
Perspectives
Recognition
Criminal Defense: White Collar (Washington, D.C.) (2023)
Healthcare: Life Sciences (2021-2022)
Healthcare: Service Providers (2021)
Credentials
Education
- J.D., Yale Law School
- A.B., Harvard College, magna cum laude
Admissions
- District of Columbia
- California
- Virginia
- U.S. Court of Appeals for the District of Columbia Circuit
- U.S. Court of Appeals for the Third Circuit
- U.S. Court of Appeals for the Fourth Circuit
- U.S. Court of Appeals for the Eleventh Circuit
- U.S. District Court, District of Columbia
- U.S. District Court, Central District of California
- U.S. District Court, Eastern District of Virginia
Clerkships
- U.S. District Court, District of Columbia, The Honorable Ellen Segal Huvelle